Abstract:In tumor-bearing state, the conversion of the system immune status makes the protumor function of neutrophils, and leading the suppression of NK cells cytotoxicity. The induced dysfunctional neutrophils could modulate the antitumor function of NK cells, but it is unclear whether and how the rebellious neutrophils modulate the NK cells anti-tumor function. Here we report that tumor-bearing neutrophils could impair NK cells cytotoxicity and the infiltration capability. Decreased CCR1 responsible for the weakened infiltration capability. Neutrophils could decrease the reactivity of NK activating receptor NKp46 and NKG2D. Induced PD-L1 expression (neutrophils) and PD-1 (NK cells) and the PD-L1/PD-1 axis were the main one mechanism of the suppression of NK cells immunity. Systemic increased G-CSF enhanced the expression of PD-L1, G-CSF/JAK2-STAT3 cell signaling pathway responsible to the upregulation of PD-L1. Tumor derived IL-18 enhances the PD-1 expression, block the IL-18 pathway by IL-18BP or knockdown the IL-18 expression by siRNA could both offset the IL-18 induced PD-1 expression. The neutrophils and NK cells crosstalk was cell-cell contact dependent, the affect of neutrophils on NK cells was disappeared when they were cultured in a separate system. These findings highlight the PD-L1/PD-1 signal on the immune suppression effect of neutrophils on NK cells. G-CSF and IL-18 producing might lead to a poor prognosis via different ways which cooperate to activate the immunosuppressive signal and weaken the antitumor affect of NK cells. Targeting G-CSF and IL-18 might be a potential approach to eliminate residual tumor cells in comprehensive strategy for tumor therapy.Funding Statement: This work was supported by National Natural Science Foundation of China (No. 81502461, 81502265), Natural Science Foundation of Hubei province (NO. 2016CFB340), Key Project of Wuhan Municipal Health Planning Commission Key Project (NO. WX15A08). Huazhong University of Science and Technology "Double Top" Construction, Project of International Cooperation (NO. 540-5001540013). Declaration of Interests: No potential conflicts of interest were disclosed. Ethics Approval Statement: BALB/c mice, 6 wks old, were purchased from Center of Medical Experimental Animals of Hubei Province (Wuhan, China) for studies approved by the Animal Care and Use Committee of Tongji Medical College (Wuhan, China).

Neutrophil depletion enhances the therapeutic effect of PD-1 antibody on glioma

PDPN Contributes to Constructing Immunosuppressive Microenvironment in IDH Wildtype Glioma

Neutrophil extracellular traps mediate the crosstalk between glioma progression and the tumor microenvironment via the HMGB1/RAGE/IL-8 axis

Neutrophils: New Critical Regulators of Glioma

IFN-γ Down-Regulates the PD-1 Expression and Assist Nivolumab in PD-1-blockade Effect on CD8+ T-lymphocytes in Pancreatic Cancer

Tumor-associated neutrophils suppress antitumor immunity of NK cells through the PD-L1/PD-1 axis

Rational targeting of immunosuppressive neutrophils in cancer

Local Release of TGF-beta Inhibitor Modulates Tumor-Associated Neutrophils and Enhances Pancreatic Cancer Response to Combined Irreversible Electroporation and Immunotherapy

The IFN-γ/PD-L1 Axis Between T Cells and Tumor Microenvironment: Hints for Glioma Anti-Pd-1/pd-l1 Therapy.

Tumor Induced PD-L1 on Neutrophils Suppress the Antitumor Immunity of NK Cells Via PD-L1/PD-1 Axis

Characterization of PD-1 upregulation on tumor-infiltrating lymphocytes in human and murine gliomas and preclinical therapeutic blockade

Elevated neutrophil-to-lymphocyte ratio induced by tumor and immune cells promotes gastric cancer progression during PD-1 antibody-based treatment

Molecular and clinical characterization of PTPN2 expression from RNA-seq data of 996 brain gliomas

Neutrophils in glioma microenvironment: from immune function to immunotherapy

Local Release of TGF‐ β Inhibitor Modulates Tumor‐Associated Neutrophils and Enhances Pancreatic Cancer Response to Combined Irreversible Electroporation and Immunotherapy

GDNF secreted by nerves enhances PD-L1 expression via JAK2-STAT1 signaling activation in HNSCC.

A combined model of serum neutrophil extracellular traps, CD8+ T cells, and tumor proportion score provides better prediction of PD‐1 inhibitor efficacy in patients with NSCLC

Neutrophil Extracellular Traps Promote T Cell Exhaustion in the Tumor Microenvironment

Monocyte depletion enhances neutrophil influx and proneural to mesenchymal transition in glioblastoma

Neutralizing IL-8 potentiates immune checkpoint blockade efficacy for glioma

Neutrophils as key regulators of tumor immunity that restrict immune checkpoint blockade in liver cancer